Virtual Medicinal Product (VMP) - Lidocaine 200mg/20ml (1%) / Adrenaline (base) 100micrograms/20ml (1 in 200,000) solution for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Lidocaine 200mg/20ml (1%) / Adrenaline (base) 100micrograms/20ml (1 in 200,000) solution for injection vials Start Date 12-03-2015 End Date
Previous Name Previous Name Lidocaine 200mg/20ml (1%) / Adrenaline 100micrograms/20ml (1 in 200,000) solution for injection vials Start Date 12-07-2004 End Date 11-03-2015
Abbreviated Name Abbreviated Name Lidocaine 200mg/Adrenaline (base) 100microg/20ml inj vials Start Date 12-03-2015
Previous Abbreviated Name Lidocaine 200mg/Adrenaline 100microg/20ml inj vials Previous Start Date 13-09-2004 Previous End Date 11-03-2015

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
20
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Perineural
Form
Solution for injection
Ontology Form/Route
solutioninjection.perineural
Name Basis
Other

Codes

ATC Code
N01BB52
BNF Start Date End Date
Current BNF 15020100 Start Date 04-04-2022 End Date
Previous BNF 15020000 Start Date 24-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
3602611000001107 07-01-2003

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Adrenaline acid tartrate Based on Base Substance Adrenaline 5 microgram 1 ml
Lidocaine hydrochloride Based on Ingredient Substance 10 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
5 vial 966 Part VIIIA Category C